banter and General Discussion, page-17397

They will do a raise to build stock and invest in manufacturing.


But for that to happen something else would need to be approved or on the way to approval.


What is the end game here?


Silviu will step down once he lands a Global Partnership for CHF or CLBP is approved in the US- I know this because I just thought it.


Mesoblast does what then ? Lonza provides cells, supply chain in place, Partners handle sales, training and marketing.


Does Mesoblast keep looking for the next big thing in cellular technology- they will certainly be cashed up to buy out early stage tech.


Or do they become a producer of allogeneic cells for countless therapies.


It's in the Lonza contract that they can buy the plant.


Look at me making stuff up.



Maybe I know someone who knows someone




Reg